SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-036408
Filing Date
2021-02-10
Accepted
2021-02-10 16:53:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d61783d424b5.htm 424B5 630361
2 GRAPHIC g61783g11t16.jpg GRAPHIC 47689
3 GRAPHIC g61783g55c63.jpg GRAPHIC 51980
4 GRAPHIC g61783g57x13.jpg GRAPHIC 51621
  Complete submission text file 0001193125-21-036408.txt   835829
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249341 | Film No.: 21614762
SIC: 2834 Pharmaceutical Preparations